Wednesday, October 9, 2019 Daily Archives

Cell Culture Media Analysis Using a Handheld Raman Analyzer with Onboard Chemometrics

by

This webcast features: Orville Dean Stuart, Technical Regional Sales Manager, Thermo Fisher Scientific This webinar presents the use of a handheld Raman analyzer with onboard chemometrics to verify the identify and monitor the quality and batch-to-batch variability of both dry powder chemically defined media and ready-to use liquid cell culture media. While scans of cell culture media using Thermo Scientific’s TruScan RM handheld Raman analyzer produce spectra with good Raman features, due to similar constituents and formulations, the TruTools add-on…

October 9, 2019

CDMO focus: Strategic gene therapy deals and $250m sell-off

by

Lonza strengthens gene therapy partnership with Prevail; Paragon and Brammer evolving form hyperstacks over to iCELLis units for Sarepta; Mallinckrodt sells off Biovectra. Welcome to Bioprocess Insider’s CDMO round-up. First up in this contract development and manufacturing organization (CDMO) round-up is Swiss firm Lonza, which is upping its partnership with Prevail Therapeutics. Lonza has worked on the process development of Prevail’s two lead gene therapy programs since 2018 and will now take the partnership to the next stage, using a…

October 9, 2019

Novartis supply-ready for approved wet AMD antibody fragment

by

Novartis says it is confident in its ability to supply Beovu (brolucizumab) after the single-chain antibody fragment received US FDA approval for treating wet AMD. The US Food and Drug Administration (FDA) this week approved Novartis’ anti-VEGF product Beovu for the treatment of patients with wet age-related macular degeneration (AMD) on a three-month dosing interval. A Novartis spokesperson did not divulge where the antibody fragment is made but told this publication the firm is confident in its ability to meet…

October 9, 2019

J&J expands Irish footprint with €300m plant and 200 new jobs

by

J&J subsidiary Janssen has opened a 206,000 square-foot biologics manufacturing facility at its site in Ringaskiddy, county Cork. Janssen Science Ireland announced its plans to construct a €300 million biomanufacturing plant at its site in Ringaskiddy in 2017 and this week the 19,100 m2 (206,000 square feet) opened its doors. “Our manufacturing facilities in Cork are at the cutting-edge of delivering healthcare solutions, which is an important part of our credo commitment to provide the highest quality products to patients, 

October 9, 2019